Lexicon Pharmaceuticals Inc (LXRX)vsRevolution Medicines Inc (RVMD)
LXRX
Lexicon Pharmaceuticals Inc
$2.00
-0.99%
HEALTHCARE · Cap: $1.01B
RVMD
Revolution Medicines Inc
$205.11
+0.66%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Lexicon Pharmaceuticals Inc generates 5489% more annual revenue ($41.47M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -147.4%. RVMD earns a higher WallStSmart Score of 24/100 (F).
LXRX
Avoid16
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Conservative balance sheet, low leverage
Areas to Watch
Smaller company, higher risk/reward
ROE of -12.9% — below average capital efficiency
Revenue declined 97.6%
Earnings declined 63.4%
Trading at 16.9x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : LXRX
LXRX has a balanced fundamental profile.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : LXRX
The primary concerns for LXRX are Market Cap, Return on Equity, Revenue Growth.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
LXRX profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
RVMD is growing revenue faster at -95.2% — sustainability is the question.
LXRX generates stronger free cash flow (-24M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 16/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lexicon Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?